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Abstract
Spinal and bulbar muscular atrophy (SBMA) is an X-linked, neuromuscular neurodegenerative disease for which
there is no cure. The disease is characterized by a selective decrease in fast-muscle power (e.g., tongue pressure, grip
strength) accompanied by a selective loss of fast-twitch muscle fibers. However, the relationship between neuromuscular junction (NMJ) pathology and fast-twitch motor unit vulnerability has yet to be explored. In this study, we used
a cross-model comparison of two mouse models of SBMA to evaluate neuromuscular junction pathology, glycolyticto-oxidative fiber-type switching, and cytoskeletal alterations in pre- and postsynaptic termini of tibialis anterior (TA),
gastrocnemius, and soleus hindlimb muscles. We observed significantly increased NMJ and myofiber pathology in
fast-twitch, glycolytic motor units of the TA and gastrocnemius compared to slow-twitch, oxidative motor units of
the soleus, as seen by decreased pre- and post-synaptic membrane area, decreased pre- and post-synaptic membrane colocalization, increased acetylcholine receptor compactness, a decrease in endplate area and complexity, and
deficits in neurofilament heavy chain. Our data also show evidence for metabolic dysregulation and myofiber atrophy
that correlate with severity of NMJ pathology. We propose a model in which the dynamic communicative relationship
between the motor neuron and muscle, along with the developmental subtype of the muscle, promotes motor unit
subtype specific vulnerability, metabolic alterations, and NMJ pathology.
Keywords: SBMA, Neuromuscular junction, Skeletal muscle, Motor neuron
Background
Spinal and bulbar muscular atrophy (SBMA; Kennedy’s
Disease) is an X-linked neuromuscular neurodegenerative disease caused by a polyglutamine-encoding CAG
repeat expansion in exon 1 of the androgen receptor
(Ar) gene [13, 30]. SBMA is characterized by limb and
bulbar muscle weakness and atrophy and by the loss of
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lower motor neurons from the spinal cord and brainstem
motor nuclei. Mutant AR-containing intranuclear inclusions are observed in remaining neurons, muscle, and to
a lesser extent in tissues throughout the body that show
little or no degenerative phenotype. The combination of
lower motor neuron loss and muscle atrophy results in
symptoms such as fasciculations, dysarthria, dysphagia,
muscle weakness, and reduced muscle contractility [2].
Symptoms typically present between 30 and 50 years
of age, and bulbar degeneration predisposes patients to
potentially fatal aspiration pneumonia [17, 64]. Due to
the requirement for testosterone for disease progression, SBMA is male-specific, although female patients are
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known to show mild or subclinical symptoms [65]. Currently there is no cure for this disease.
SBMA was historically classified as a lower motor
neuron disease, and in SBMA patients, the loss of lower
motor neurons results in a decrease in the number of
functioning motor units compared to age-matched controls [67]. Mouse models recapitulate many aspects of
motor neuron pathology such as intranuclear inclusions
containing polyglutamine-expanded AR, electrophysiological alterations, neuronal loss, and decreased somal
unphosphorylated neurofilament heavy chain [5, 9, 26,
71]. While earlier studies focused on the role of neurogenic degeneration of the motor unit in SBMA pathogenesis, many recent studies have elucidated a primary
role for myogenic atrophy in SBMA. For example, when
CAG-expanded Ar is selectively silenced in muscles of
SBMA mouse models, disease phenotypes are substantially rescued, providing evidence for a primary myopathic disease mechanism [9, 34]. Moreover, metabolic
and transcriptional dysregulation in muscle fibers could
have non-cell autonomous effects on the health of the
innervating motor neuron [47, 58], potentially contributing to motor neuron pathology in SBMA and degeneration of the motor unit.
Evidence of both myogenic and neurogenic disease
processes places the neuromuscular junction (NMJ), the
chemical synapse of the motor unit, at a focal point in
SBMA pathogenesis. The unique synaptic structure of
the NMJ ensures a high safety factor for neuromuscular
transmission. Axon terminals of a pre-synaptic motor
neuron must completely overlap with the pretzel-shaped
acetylcholine receptor (AChR) clusters on the postsynaptic endplate to ensure that an action potential in the
motor neuron reliably promotes contraction of the muscle fiber [31]. NMJs in multiple neuromuscular disease
states including amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and SBMA show a variety
of structural pathologies such as fragmented AChR clusters, lack of AChR colocalization with the presynaptic
terminal, denervation, loss of cytoskeletal elements, and
a change in size or complexity (i.e., branching pattern)
[36, 43, 51, 60]. Previous studies in SBMA mouse models
revealed significant changes in NMJ structure and function [7, 27, 51, 60, 72]; however, the specificity of NMJ
pathology to muscle and motor unit subtype has yet to be
established.
Motor units, defined as the lower motor neuron and
the muscle fibers it innervates, are classified as slowtwitch oxidative (Type I), fast-twitch oxidative (Type
IIa), or fast-twitch glycolytic (Type IIb/x) based on the
contractile properties of the muscular cytoskeleton. ‘Oxidative’ and ‘glycolytic’ refer to the metabolic machinery
used to create ATP in the specified fiber type. Glycolytic

(fast-twitch fibers) rely on glycolysis to provide energy,
while oxidative (generally slow-twitch fibers) use both
glycolysis and oxidative phosphorylation to create a sustained source of ATP for prolonged contraction. Importantly, the contractile properties of the muscle fiber are
determined by the firing rate of its innervating motor
neuron, which promotes a transcriptional program
specific to muscle fiber types [66]. Preferential loss of
fast-twitch motor units has been seen in other neurodegenerative diseases such as ALS [11, 18, 19, 54], and
glycolytic-to-oxidative fiber-type switching has been seen
in mouse models of SBMA [7, 55, 58], as well as during
normal aging [25]. In SBMA patients, decreased tongue
pressure and grip strength, along with fast-twitch muscle
fiber atrophy, suggest selective fast motor unit degeneration [17, 23, 73]; however, the vulnerability of fast-twitch
motor units, and the relationship between NMJ structural pathology and the differential vulnerability of fastand slow-twitch motor units in SBMA has yet to be
evaluated.
In this study, we aimed to evaluate the NMJ pathology in relation to fiber type vulnerability to further
understand the intersection of neuronal and myofibrillar
pathology in multiple muscles of SBMA mouse models.
We determined the relationship between NMJ structural
pathology and motor unit subtype (fast- vs. slow-twitch)
using two mouse models of SBMA—a transgenic, CNS
expression-focused mouse model of SBMA [5] and a
knock-in mouse model of SBMA [74, 75]. We evaluated
multiple aspects of NMJ morphology in three muscles
of distinct fiber type—gastrocnemius and tibialis anterior (TA), both largely fast-twitch, glycolytic muscles,
and soleus, a largely slow-twitch, oxidative muscle. We
hypothesized that NMJ structural pathology in these
mouse models would correlate with the increased vulnerability of fast-twitch motor units seen in both SBMA
mouse models and patients, showing, for example,
increased endplate fragmentation and decreased preand post-synaptic colocalization.
We observed significant NMJ structural pathology
in all three muscles of both mouse models, with more
severe NMJ pathology in muscles composed primarily of fast-twitch myofibers. Cytoskeletal alterations
in both motor neurons and muscle, namely decreased
NFH and altered myosin heavy chain expression, provide evidence for both neuropathic and myopathic
contributions to NMJ pathology in these SBMA models. Analysis of muscle histology to further understand myofiber changes in relation to NMJ pathology
revealed a prominent shift to oxidative metabolism and
a decrease in cross sectional area in all muscles of both
mouse models, with fast-twitch muscles showing more
severe muscle pathology. These quantitative studies
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provide significant evidence of correlated neuronal
and muscular dysregulation that contribute to NMJ
pathology, which is more severe in fast-twitch motor
units. We propose a model in which both the contractile properties of the motor unit and the developmental
subtype of the muscle contribute to disease pathology
at the NMJ of SBMA model mice and highlight the
importance of robust and quantitative NMJ evaluations
for the understanding these contributions.

each muscle were imaged. Antibodies used are provided
in supplementary methods.

Methods

Image analysis of neuromuscular junctions

At least 20 neuromuscular junctions from each muscle were evaluated with the following protocol using
ImageJ, adapted from Jones et al. [24]. Full analysis protocol is provided in supplementary methods (schematic
shown in Additional File 1: Fig. S1).
Immunohistochemical analysis of muscle

Animal care and experimental procedures were conducted in accordance with the Thomas Jefferson University Institutional Animal Care and Use Committee
(IACUC). Transgenic Model: The transgenic model,
previously described in Chevalier-Larsen et al., 2004 [5],
uses the prion protein promoter to express an expanded
human AR containing 112 CAG repeats (+ 1 CAA
codon, encoding a total of 113 glutamine residues within
the human AR protein) primarily in the central nervous
system. Knock-in Model: The knock-in model, previously
described in Yu et al., [74, 75], replaces part of the exon
1 of the mouse androgen receptor gene with a portion
of human Ar exon 1 containing 112 CAG repeats (+ 1
CAA codon, encoding a total of 113 glutamine residues
within the human AR protein) resulting in endogenous
expression levels and pattern of polyglutamine expanded
androgen receptor.

NADH-TR (diaphorase): Muscle sections were incubated
in NADH-tetrazolium solution (NADH, Sigma N8129;
Nitro blue tetrazolium, Sigma N6876) for 30 min at 37 °C.
Unbound solution was removed from muscle sections
using by successive washes with 30% acetone, 60% acetone,
90% acetone, 60% acetone, and 30% acetone. Sections were
mounted with CitriSolve. Images were taken at 10X using
an EVOS M7000 microscope. Intensity of NADH staining
and cross-sectional area were analyzed in ImageJ by manually selecting each muscle fiber and recording mean intensity
and area. 3 images were analyzed (≥ 574 fibers) per muscle
for each genotype.
Androgen Receptor: Muscle sections of gastrocnemius
from one knock-in mouse and one transgenic mouse were
fixed in 4% PFA for 20 min, and stained as in Montie et al.
[46]. Images were taken at consistent exposure on an EVOS
M7000 microscope at 60x. 15 images per muscle were evaluated in ImageJ by selecting a region of interest for each muscle fiber and measuring mean intensity of AR fluorescence.
All images were taken at the same exposure.

Neuromuscular junction analysis

Western blot analysis

Mouse models

Muscles of 3 mice of each genotype (1-year-old nontransgenic and transgenic mice, and 6-month-old
wildtype and knock-in mice) were dissected. Gastrocnemius, tibialis anterior, and soleus muscles were dissected from SBMA mice and littermate controls and
immediately placed into 4% paraformaldehyde (PFA)
for 30 min. Muscles were then teased into small bundles under a dissecting microscope in PBS and stained
according to Martin et al., 2015 [41]. Briefly, teased muscle was incubated in 0.1 M glycine solution, incubated in
AlexaFluor-647-conjugated α-bungarotoxin, then incubated in pre-cooled methanol. Muscles were incubated
in blocking buffer (2% bovine serum albumin in 0.2%
Triton-X-100) and then incubated with primary and then
secondary antibodies in blocking buffer. Muscles were
mounted on microscope slides using Fluoromount-G
mounting medium and imaged on a Nikon A1R confocal
microscope. At least 20 neuromuscular junctions from

Gastrocnemius, tibialis anterior, and soleus muscles
were dissected from 3 mice of each genotype and flashfrozen in liquid nitrogen (12-month-old non-transgenic
and transgenic, 9 month old knock-in mice). Muscles
were manually pulverized with a mortar and pestle
and added to lysis buffer (50 mM Tris, 150 mM NaCl,
1% Triton-X-100, 1% sodium deoxycholate, 0.1% SDS,
2 mM EDTA, 1X Roche Protease Inhibitors, PMSF).
Lysate was then homogenized using a Cole-Parmer
LABGEN 850 Homogenizer; 110 V at 13,000 rpm
3 × 20 s. Lysate was then sonicated and centrifuged at
4 °C at 15,000 g for 10 min. Protein concentration was
measured using the BioRad DC Assay Kit. 50ug of protein extract was electrophoresed on TGX Stain-Free
FastCast™ polyacrylamide gel (BioRad). Membrane was
blocked in 0.05% TBST with 5% milk. Primary and secondary antibody details are provided in supplementary
methods.
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Results
To investigate the structural pathology of the NMJ in
slow- and fast-twitch motor units, soleus, gastrocnemius, and TA muscles were dissected from two mouse
models of SBMA and evaluated for multiple features
of NMJ pathology. The first mouse model, hereafter
referred to as the knock-in model [74, 75], exhibits a
progressive decrease in strength as early as 12 weeks
of age, both neurogenic and myopathic muscle atrophy
(with myopathic features preceding neurogenic atrophy), and fiber-type grouping [16, 58, 74, 75]. These
mice also show partial fragmentation at the NMJ without denervation at 6 months of age [51]. The second
mouse model used in this study, hereafter referred to
as the transgenic model, exhibits slowly progressive
motor deficits as early as 8 weeks of age and shows
mutant androgen receptor (AR) intranuclear inclusions
in spinal cord and skeletal muscle. It also exhibits muscle atrophy and shows no motor neuron loss in vivo,
although extensive motor neuron death is observed
in vitro upon hormone treatment [20, 45, 48, 50].
To understand the relationship between NMJ and muscle pathology, we aimed to evaluate both transgenic and
knock-in mice at 6-months of age due to the presence of
significant motor dysfunction and muscle atrophy in both
models [5, 74, 75]. At 6-months of age, the knock-in mice
show no motor neuron loss [34], and the transgenic mice
show no motor neuron loss throughout their lifespan [5].
This cross-model comparison aimed to evaluate NMJ
pathology at timepoints known to be devoid of motor
neuron loss. However, due to the lack of NMJ pathology
in the transgenic mice at 6-months of age (Additional File
1: Fig. S2), we evaluated the transgenic model at 1 year of
age and the knock-in model at 6-months of age in order
to better understand the extent of NMJ pathology in the
absence of motor neuron loss.

from both mouse models were evaluated for NMJ
pathology (Additional File 1: Fig. S1). Post-synaptic
area was found to be substantially decreased in both
transgenic and knock-in mice compared to control littermates (Fig. 1A–C). Endplate area was also substantially decreased in both models (Fig. 1D, E). AChR
compactness, calculated by dividing post-synaptic area
by endplate area, was increased in both models but only
reached statistical significance in the knock-in model
(Fig. 1F, G). Both models showed a decrease in endplate
complexity, but this only reached statistical significance
in knock-in NMJs (Fig. 1H, I). Both models showed a
modest increase in the percentage of fragmented NMJs;
however, this did not reach statistical significance
(Fig. 1J, K), highlighting the value of exploring quantitative measurements of NMJ pathology. Presynaptic area,
measured using localization of synaptic vesicle protein
synaptophysin, was significantly reduced in both models (Fig. 2A–C). Pre- and post-synaptic colocalization
was also decreased in both models (Fig. 2D–F). These
detailed quantitative data (Additional File 1: Table S1)
provide evidence for significant pre- and post-synaptic
pathology at the NMJs of the primarily fast-twitch gastrocnemius muscle in two mouse models of SBMA.
Previous studies in a transgenic model of SBMA
revealed a significant reduction in unphosphorylated
neurofilament heavy chain (uNFH) in the cell bodies of
spinal motor neurons [5]. At the axon terminal of NMJs
in the gastrocnemius, uNFH intensity was significantly
decreased in both models (Additional File 1: Fig. S3).
Moreover, localization of uNFH to the axon terminal, as measured by colocalization with fluorescently
tagged α-BTX, was decreased in gastrocnemius of the
knock-in model (Fig. 3C, D), and trended lower in the
transgenic model (Fig. 3A, B). Since NFH is increasingly phosphorylated as it travels in the anterograde
direction towards the axon terminal, we also evaluated
phosphorylated NFH (pNFH) localization to the axon
terminal through colocalization with synaptophysin
(Fig. 3E, G). In both mouse models, although pNFH
intensity was unchanged (Additional File 1: Fig. S3),

Gastrocnemius muscle shows significant neuromuscular
junction pathology in two mouse models of SBMA.

To understand how mutant AR expression affects the
NMJ, the primarily fast-twitch gastrocnemius muscles

(See figure on next page.)
Fig. 1 Gastrocnemius NMJs show significant alterations in post-synaptic area, endplate area, AChR compactness, and post-synaptic complexity
in two mouse models of SBMA. A Post-synaptic membranes of NMJs from gastrocnemius muscle were labeled with fluorescently tagged
α-bungarotoxin (α-BTX). Transgenic mice showed significantly decreased post-synaptic area (B; p < 0.0001) and endplate area (D; p < 0.0001), and a
trending reduction in post-synaptic complexity (H). AChR compactness showed a trending increase in transgenic mice compared to NTg controls
(F). While the percentage of fragmented endplates was slightly increased, this did not reach statistical significance (J). Knock-in mice showed
significant decreases in post-synaptic area (C; p < 0.0001), endplate area (E; p < 0.0001), and post-synaptic complexity (I; p < 0.05). AChR compactness
was significantly increased in knock-in mice compared to wild-type littermates (G; p < 0.001). While the percentage of fragmented endplates in
knock-in mice was increased, this did not reach statistical significance (K). Mann–Whitney Test was used to evaluate statistical significance for
distributions. Student’s t-test was used to evaluate fragmentation. NTg, Non-transgenic; Tg Transgenic; WT Wild-type; KI Knock-in
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Fig. 2 Gastrocnemius NMJs show significant decreases in pre-synaptic area and pre- and post-synaptic colocalization in transgenic and knock-in
models of SBMA. Pre-synaptic terminals were stained with synaptic vesicle marker synaptophysin and measured for pre-synaptic area and
colocalization with post-synaptic membrane, labeled with fluorescently tagged a-bungarotoxin. Arrows point to NMJ with low synaptophysin
staining. Synaptophysin image in A were merged with α-BTX images for panel D. A Gastrocnemius NMJs showed significantly decreased
pre-synaptic area in transgenic and knock-in mice (B NTg vs Tg p < 0.0001; C WT vs KI p < 0.0001). D Gastrocnemius NMJs showed significantly
decreased pre- and post-synaptic colocalization in transgenic and knock-in mice (E NTg vs Tg, p < 0.001; F WT vs KI, p < 0.01). Mann–Whitney Test was
used to evaluate statistical significance for distributions. Abbreviations: NTg, non-transgenic; Tg, transgenic; WT, wild-type; KI, knock-in

pNFH colocalization with the pre-synaptic terminal
was decreased (Fig. 3F). These data provide evidence
for a significant deficit in NFH at the axon terminal,
which correlates with the substantial pre- and post-synaptic alterations in NMJs of the gastrocnemius.

Fast‑twitch tibialis anterior motor units show significant
changes in the post‑synaptic membrane of the NMJ.

To further evaluate the pathology of fast-twitch motor
units in these two mouse models of SBMA, we evaluated NMJs in fast-twitch TA using the same procedure

(See figure on next page.)
Fig. 3 Gastrocnemius NMJs show significant changes in localization of phosphorylated and unphosphorylated neurofilament heavy chain
to the axon terminal in two mouse models of SBMA. (A, C, E, G) To evaluate localization of cytoskeletal structural element NFH to the axon
terminal, NMJs from gastrocnemius were stained with α-BTX, synaptophysin, and SMI31 (phospho-NFH) or α-BTX, TUJ1 (BIII-tubulin), and SMI32
(unphospho-NFH) and evaluated for colocalization with synaptophysin or α-BTX, respectively. B, D Both transgenic (trending, p = 0.0618) and
knock-in mice (p < 0.0001) showed decreased uNFH localization to the terminal. F, H Both transgenic (p < 0.001) and knock-in (p < 0.01) mice also
showed significantly decreased pNFH colocalization with the terminal. Mann–Whitney Test was used to evaluate statistical significance. uNFH
Unphosphorylated neurofilament heavy chain; pNFH Phosphorylated neurofilament heavy chain; NTg Non-transgenic; Tg Transgenic; WT Wild-type;
KI Knock-in
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Fig. 4 Fast-twitch tibialis anterior motor units show significant changes in post-synaptic membrane of NMJ. Post-synaptic membranes of NMJs
from tibialis anterior (TA) muscle were labeled with fluorescently tagged α-bungarotoxin (α-BTX). A Transgenic mice showed significantly decreased
post-synaptic area (B; p < 0.01) and endplate area (D; p < 0.01) without an increase in AChR compactness (F). Transgenic mice showed a significant
increase in the percentage of fragmented NMJs (H; p < 0.05). Knock-in mice did not show an increase in fragmentation (I), post-synaptic area (C) or
endplate area (E) but did show an increase in AChR compactness (G; p < 0.05). Mann–Whitney Test was used to evaluate statistical significance for
distributions. Student’s t-test was used to evaluate fragmentation. Abbreviations: Ntg, non-transgenic; Tg, transgenic; WT, wild-type; KI, knock-in

described for the analysis of gastrocnemius. In the
transgenic mouse model, TA NMJs showed a significant
decrease in post-synaptic area and endplate area, without a corresponding increase in acetylcholine receptor
compactness (Fig. 4A, B, D, F). However, unlike gastrocnemius NMJs, TA NMJs in the transgenic model showed
a significant increase in fragmentation, a well-studied

indicator of NMJs that are degenerating or remodeling
[63]. In comparison, NMJs of knock-in TA showed a
significant change only in AChR compactness (Fig. 4G),
despite showing no significant differences in post-synaptic area or endplate area (Fig. 4C, E). Knock-in TA
NMJs showed no change in fragmentation (Fig. 4I). There
were no significant changes in endplate complexity or in
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any pre-synaptic markers, including area and pre- and
postsynaptic colocalization, in the TA of either model
(Additional File 1: Fig. S4). These data (Additional File 1:
Table S1) provide evidence for more limited NMJ pathology in the NMJs of TA, observed primarily in the postsynaptic membrane, in contrast to the more substantial
pre- and post-synaptic pathology seen in the gastrocnemius muscle, despite the fact that both muscles contain
primarily fast-twitch muscle fibers.
Although pathology at the NMJ of TA muscles in transgenic mice was observed primarily at the post-synaptic
membrane (post-synaptic area, endplate area, and fragmentation), alterations in pNFH intensity (Additional
File 1: Fig. S5) and localization to the axon terminal
(Fig. 5E, F) were present at the pre-synaptic membrane
of NMJs of the TA in transgenic mice. In addition, uNFH
localization to the pre-synaptic terminal was also significantly decreased in this model (Fig. 5A, B), providing evidence for general NFH depletion at the NMJ. In
contrast, the NMJs of TA in knock-in mice showed a significant increase in pNFH staining intensity compared
to littermate controls (Additional File 1: Fig. S5) and did
not show changes in uNFH intensity or localization of
pNFH or uNFH to the pre-synaptic terminal (Fig. 5C, D,
G, H). The changes in NFH at TA NMJs appear to correlate with the severity of NMJ pathology observed in both
models – the transgenic model, which showed multiple
signs of NMJ structural deficits, also showed substantial decreases in NFH, while the knock-in model, which
only showed alterations in AChR compactness, showed
increased pNFH intensity and no changes in colocalization of NFH with the pre-synaptic terminal.

area, presynaptic area, or fragmentation (Additional
File 1: Fig S6). Transgenic mice also showed a significant decrease in pNFH colocalization with the pre-synaptic terminal, without alterations in pNFH intensity,
uNFH intensity, or uNFH localization to the terminal
(Fig. 7A, B, E, F; Additional File 1: Fig. S7). Moreover,
soleus NMJs from knock-in mice exhibited no significant changes in any of the evaluated parameters
(Additional File 1: Fig. S6), except a decrease in uNFH
intensity and uNFH localization to the pre-synaptic
terminal (Fig. 7C, D, G, H; Additional File 1: Fig. S7).
These data support the hypothesis that slow-twitch
motor units exhibit substantially less NMJ pathology
than fast-twitch motor units, as both models exhibited
stark differences in NMJ pathology between fast- and
slow-twitch motor units (Additional File 1: Table S1).

Slow‑twitch soleus shows less NMJ pathology
than fast‑twitch muscles

To evaluate differences between fast-twitch and slowtwitch motor unit pathology, we evaluated NMJs of
the slow-twitch soleus muscle in both mouse models
of SBMA. In transgenic mice, soleus NMJs exhibited
modestly decreased endplate area, pre- and postsynaptic colocalization, and endplate complexity (Fig. 6),
with a trend toward an increase in AChR compactness. There were no significant changes in postsynaptic

AR expression is not significantly different in muscles
of transgenic and knock‑in mice.

To further understand possible mechanisms driving
the heightened NMJ pathology in transgenic mice compared to knock-in mice in both TA and soleus muscles, we considered the differences in AR expression
between the two models. AR expression is substantially
greater in the spinal cord of transgenic mice compared
to non-transgenic mice [5, 77]. Because knock-in mice
express polyglutamine-expanded AR under mouse
regulatory gene elements, AR expression in these mice
is equal to that in non-transgenic mice which endogenously express non-expanded AR. Additionally, while
the transgenic mice primarily express polyglutamineexpanded AR in the central nervous system, polyglutamine-containing intranuclear inclusions are seen in
muscle (Additional File 1: Fig. S8). We evaluated AR
protein expression in gastrocnemius muscle fibers from
transgenic and knock-in mice (Additional File 1: Fig.
S8) and observed no significant differences between the
two models in AR intensity. Therefore, the differences in
NMJ pathology between transgenic and knock-in mice
are unlikely to be attributed to elevated AR expression
in transgenic muscle. Our results thus suggest that the
increased levels of polyglutamine-expanded AR in the

(See figure on next page.)
Fig. 5 Neurofilament heavy chain (NFH) localization to the axon terminal is altered in transgenic but not knock-in mice in tibialis anterior. A, C,
E, G To evaluate localization of cytoskeletal structural element NFH to the axon terminal, NMJs from tibialis anterior were stained with α-BTX,
synaptophysin, and SMI31 (phospho-NFH) or α -BTX, TUJ1 (BIII-tubulin, and SMI32 (unphospho-NFH) and evaluated for colocalization with the
synaptophysin or α-BTX, respectively. Consistent with the trends seen in pre- and post-synaptic NMJ measurements, transgenic mice showed
significantly decreased uNFH localization to the axon terminal (B; p < 0.0001) and pNFH colocalization with terminal (F; p < 0.0001) while knock-in
mice did not show changes in either of these measurements (D, H). Mann–Whitney Test was used to evaluate statistical significance. uNFH
Unphosphorylated neurofilament heavy chain; pNFH Phosphorylated neurofilament heavy chain; NTg Non-transgenic; Tg Transgenic; WT Wild-type;
KI Knock-in

Molotsky et al. Acta Neuropathologica Communications

Fig. 5 (See legend on previous page.)

(2022) 10:97

Page 10 of 22

Molotsky et al. Acta Neuropathologica Communications

(2022) 10:97

Page 11 of 22

Fig. 6 Slow-twitch soleus shows moderate NMJ pathology in transgenic, but not in knock-in, model of SBMA. Pre-synaptic membranes of NMJs
from soleus muscle were stained with synaptic vesicle marker synaptophysin and post-synaptic membranes were labeled with fluorescently tagged
α-bungarotoxin (α-BTX; A). Transgenic mice showed a significant decrease in endplate area (B; p < 0.05), pre- and post-synaptic colocalization
(D; p < 0.05), and post-synaptic complexity (E; p < 0.001). AChR compactness trended to an increase in transgenic mice, but this did not reach
statistical significance (C). Knock-in mouse NMJs of the soleus did not show any significant changes in NMJ pathology compared to WT littermates
(Additional File 1: Fig. S6). Mann–Whitney Test was used to evaluate statistical significance. NTg Non-transgenic; Tg Transgenic; WT Wild-type; KI
Knock-in

spinal cord of the transgenic mice likely contribute to
the greater NMJ pathology in transgenic soleus and TA
muscles.
Acetylcholine receptor subunit expression is altered
in SBMA muscle

Previous studies revealed increased AChR gamma
mRNA in transgenic and knock-in mouse models of
SBMA, corresponding to electrophysiological changes
in NMJ transduction in extensor digitorum longus and
levator ani muscles [71]; therefore, we explored whether
AChR gamma protein levels correlated with NMJ pathology. Nicotinic AChRs are composed of five subunits

– two alpha, one beta, one delta, and either one gamma
or epsilon subunit, depending on the developmental
stage of the organism, with the epsilon subunit expressed
at mature NMJs and the gamma subunit expressed in
fetal or denervated NMJs [44, 69]. Gamma subunits
are also expressed at the NMJs of intrafusal muscle fibers [15]. We evaluated AChR gamma protein expression
by Western blot and observed a trend toward decreased
expression in the soleus of both transgenic and knockin mice (Additional File 1: Fig. S9A). In contrast to these
observations in the soleus, the TA exhibited increased
AChR gamma levels in knock-in mice, which similarly
trended higher in transgenic mice (Additional File 1:

(See figure on next page.)
Fig. 7 Soleus NMJs show significant decrease in localization of NFH to the axon terminal. A, C, E, G To evaluate localization of cytoskeletal structural
element NFH to the axon terminal, NMJs from tibialis anterior were stained with α-BTX, synaptophysin, and SMI31 (phospho-NFH) or α-BTX, TUJ1
(BIII-tubulin, and SMI32 (unphospho-NFH) and evaluated for colocalization with the synaptophysin or α-BTX, respectively. B Transgenic mice
showed no changes in uNFH localization to the terminal; however, knock-in mice showed a significant decrease in uNFH localization with the
terminal (D; p < 0.05). D In contrast, pNFH colocalization with the terminal was significantly decreased in transgenic mice (E; p < 0.01) but not in
knock-in mice (F). Mann–Whitney Test was used to evaluate statistical significance. uNFH Unphosphorylated neurofilament heavy chain; pNFH
Phosphorylated neurofilament heavy chain; NTg Non-transgenic; Tg Transgenic; WT Wild-type; KI Knock-in
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Fig. 9B). Gastrocnemius, however, did not show any
alterations in AChR gamma protein levels, despite exhibiting even greater NMJ pathology than TA (Additional
File 1: Fig. S9C). Thus, in the absence of a correlation
between AChR gamma expression and NMJ pathology,
it is unlikely that heightened AChR gamma expression
plays a role in or serves as a marker of motor unit vulnerability in these models.

models showed significantly increased NADH staining
intensity in TA, providing evidence for a similar oxidative
shift in TA muscle fibers (Fig. 8F–H). This was accompanied by a significant decrease in cross-sectional area
(Fig. 8F, I, J), as observed in gastrocnemius muscle. In
both TA and gastrocnemius muscles, the observed shift
to oxidative metabolism was more substantial in transgenic mice than in knock-in mice (Additional File 1:
Table S2).
To further understand differences in fast- and slowtwitch motor unit pathology in SBMA, we also evaluated histological changes in soleus muscle (Fig. 8K). In
knock-in mice, soleus muscle fibers showed darker staining, representing further increased oxidative metabolism
(Fig. 8K, M), as seen in gastrocnemius and TA muscles in
both models. However, unlike knock-in mice, transgenic
mice showed a significant decrease in NADH staining
(Fig. 8K, L). This unexpected result could result from an
oxidative-to-glycolytic shift as a result of altered metabolism [49] or from reduced oxidative capacity due to disease progression. It is worth noting that, while soleus
muscles of both the knock-in and transgenic mouse
models showed significant decreases in cross-sectional
area, a much more substantial decrease was observed in
transgenic mice (Fig. 8K, N) compared to knock-in mice
(Fig. 8K, O; Additional File 1: Table S2).
The combined histological and structural analyses of
muscle fibers in the two mouse SBMA mouse models
used here indicate that muscles composed of primarily fast-twitch fibers exhibit a substantial shift from
glycolytic to oxidative metabolism, with a corresponding decrease in cross-sectional area. Slow-twitch soleus
muscles, in contrast, exhibited an oxidative shift that was
observed only in the knock-in model. Irrespective of the
oxidative state of the individual muscle fibers, all muscle
fibers exhibited substantially decreased cross sectional
area, which was more severe in the transgenic mice. The
greater muscle pathology observed in the transgenic
model correlates with the increased NMJ pathology in

Muscle fibers in gastrocnemius, tibialis anterior, and soleus
muscles exhibit a shift to increased oxidative metabolism
and decreased cross‑sectional area

Because the NMJ is the chemical synapse between the
motor neuron and the muscle fibers it innervates, it is
important to consider muscle fiber changes that occur
concomitant with NMJ pathology. Using nicotinamide
adenine dinucleotide (NADH)-diaphorase staining, we
evaluated cross-sections of gastrocnemius for evidence
of muscle atrophy and fiber-type switching (Fig. 8A). As
expected, due to the high proportion of fast-twitch glycolytic fibers in gastrocnemius muscles, non-transgenic/
wild-type gastrocnemius muscle fibers showed light
staining with little pigment deposition. Both transgenic
(Fig. 8A, B) and knock-in (Fig. 8A, C) gastrocnemius
muscle fibers showed substantially increased staining
intensity, suggesting a shift to more oxidative metabolism. Moreover, the cross-sectional area of gastrocnemius muscle fibers was significantly decreased in both
transgenic (Fig. 8A, D) and knock-in mice (Fig. 8A, E).
These data reveal significant alterations in muscle fiber
composition along with evidence of muscle atrophy in
gastrocnemius of both SBMA mouse models.
To determine if the more modest NMJ pathology in TA
compared to gastrocnemius, described above (Figs. 3, 4,
Additional File 1: Figs. S3 and S4), could be due to underlying differences in muscle pathology and to further evaluate fast-twitch motor unit vulnerability in the knock-in
and transgenic mouse models, we also performed
NADH-diaphorase staining of TA muscles (Fig. 8F). Both

(See figure on next page.)
Fig. 8 Muscle fibers in gastrocnemius, tibialis anterior, and soleus muscles show an increase in NADH-diaphorase staining and a decrease
in cross-sectional area. Muscle sections were stained with nicotinamide adenine dinucleotide (NADH)-disaphorase to assess oxidative state.
A–C Gastrocnemius showed an increase in NADH staining intensity in both transgenic (p < 0.0001) and knock-in (p < 0.001) mice. D, E This was
accompanied by a decrease in cross sectional area (CSA) in both models (transgenic p < 0.0001; knock-in p < 0.0001). F Tibialis anterior also showed
a significant increase in NADH staining intensity in both models (G, H; transgenic p < 0.0001; knock-in p < 0.0001) along with a significant reduction
in cross-sectional area (I, J; transgenic p < 0.0001; knock-in p < 0.0001). K In soleus, NADH intensity was shifted in opposite directions across the two
models. L, M The transgenic model showed a significant decrease in NADH staining intensity (L; p < 0.0001) while knock-in mice showed an increase
in staining intensity (M, p < 0.0001). (N, O) Both models showed a decrease in cross sectional area, although this is more severe in transgenic mice
(transgenic p < 0.0001; knock-in p < 0.01). Mann–Whitney Test was used to evaluate statistical significance. NTg Non-transgenic; Tg Transgenic; WT
Wild-type; KI Knock-in; CSA, Cross-sectional area
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Fig. 9 Cytoskeletal elements vinculin and myosin heavy chain (I, IIA, IIB) are altered in fast- and slow-twitch muscles. Cytoskeletal protein vinculin
was increased in A gastrocnemius, E tibialis anterior, and I soleus muscles in 12-month-old transgenic and 9-month-old knock-in mouse models
of SBMA. In tibialis anterior, both transgenic (p < 0.05) and knock-in mice (p < 0.01) showed significant increases in vinculin. Vinculin increase only
reached statistical significance in knock-in mice in soleus (p < 0.05) and gastrocnemius (p < 0.01). B Gastrocnemius muscle showed a significant
decrease in MHC I in both transgenic (p < 0.05) and knock-in mice (p < 0.05). C MHC IIA was unaltered in gastrocnemius of transgenic and knock-in
mice. D Knock-in mice showed a significant decrease in MHC IIB levels (p < 0.05) in gastrocnemius, which did not occur in transgenic mice. F Tibialis
anterior showed a significant decrease in MHC I in both transgenic (p < 0.01) and knock-in (p < 0.05) mice. G Tibialis anterior showed undetectable
levels of MHCIIA. Knock-in soleus lysate used as positive control. H Tibialis anterior showed a significant decrease in MHC IIB in both transgenic
(p < 0.01) and knock-in (p < 0.0001) mice. J Soleus muscle showed a significant increase in MHC I in both transgenic (p < 0.05) and knock-in mice
(p < 0.05). K Soleus muscle also showed an increase in MHC IIA in both transgenic (p < 0.05) and knock-in (p < 0.05) mice. L As expected, soleus did
not express MHC IIB in non-transgenic, transgenic, or knock-in mice. NTg gastrocnemius lysate used as positive control. Student’s t-test was used
to evaluate statistical significance. NTg Non-transgenic; Tg Transgenic; WT Wild-type; KI, Knock-in; MHC I Myosin heavy chain type 1; MHC II Myosin
heavy chain type 2A; MHC IIB Myosin heavy chain type 2B; *p < 0.05; **p < 0.01, ****p < 0.0001

this model, possibly as a result of the older age of these
mice.
Muscle cytoskeletal protein expression is significantly
altered in transgenic and knock‑in mice

Vinculin, a cytoskeletal component of striated muscle, is
present in significantly greater quantities in slow-twitch,

oxidative, muscle fibers than in fast-twitch, glycolytic,
muscle fibers, and meta-vinculin, a vinculin splice isoform, is present only in fast-twitch muscle fibers of
wild-type mice (Fig. 9) [8]. Denervation of TA in multiple mouse models resulted in increased vinculin levels
[57], leading us to question whether vinculin levels in
the three muscles evaluated here were altered. Western
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blot analysis of gastrocnemius, TA, and soleus revealed
increased vinculin levels in all three muscles of knock-in
mice and in TA of transgenic mice (Fig. 9A, E, I), with
a trending increase in gastrocnemius and soleus of the
transgenic mice. This increase in vinculin expression is
consistent with a shift in these muscles to a more oxidative metabolism, as vinculin is highly expressed in slowtwitch muscle fibers to enable sustained contraction [8].
To further understand a possible fast-to-slow fiber-type
switch and the glycolytic-to-oxidative metabolic shift, we
evaluated myosin heavy chain (MHC) isoform expression
in soleus, TA, and gastrocnemius of both mouse models. Contrary to our hypothesis that gastrocnemius and
TA muscles would exhibit a switch to increased expression of an oxidative, slow-type muscle MHC (MHC type
I), gastrocnemius and TA showed a significant decrease
in MHC I expression in both transgenic and knock-in
muscle (Fig. 9B, F). As expected, both of these primarily
fast-twitch muscles showed significantly decreased fasttwitch MHC isoform, MHC IIB, although in gastrocnemius this only reached significance in the knock-in mice
(Fig. 9D, H). MHC IIA, primarily found in oxidative fasttwitch fibers, was not significantly changed in gastrocnemius (Fig. 9C) and was undetectable in TA. Together,
these data point to a decrease in overall MHC protein
expression rather than a switch in contractile fiber-type.
Soleus muscles in both transgenic and knock-in mice
showed a significant increase in MHC I and MHC IIA
expression compared to non-transgenic controls (Fig. 9J,
K). As expected, the soleus of all three genotypes did not
express fast-twitch myosin heavy chain, MHC IIB.

soleus muscle would show little to no evidence of NMJ
pathology.
In this study, our data revealed, as expected, that fasttwitch motor units of the gastrocnemius and TA showed
more severe NMJ pathology than slow-twitch motor
units of the soleus, and that this difference correlated
with metabolic and structural changes in the innervated
muscle fibers. However, our observations suggest a more
complex interpretation than originally hypothesized, as
NMJ pathology in the TA was limited to post-synaptic
changes only in the transgenic model and was less severe
than NMJ pathology in the gastrocnemius, even though
both are considered fast-twitch muscles. One possible
explanation for these observations is the developmental difference between gastrocnemius and TA in AChR
clustering. It is known that, in response to disease and/
or injury, both myofibers and motor neurons reinitiate
the developmental program [21, 22, 78]. During development, TA myofibers exhibit fast-synapsing (FaSyn)
characteristics, while gastrocnemius and soleus exhibit
delayed-synapsing (DeSyn) features [53]. FaSyn TA
myofibers focally cluster AChRs and align motor nerves
with AChR clusters at a substantially faster rate during development than DeSyn gastrocnemius and soleus
myofibers, and differences in AChR clustering occur even
in the absence of an innervating motor neuron [53]. This
developmental difference impacted disease severity in
a model of MuSK-induced myasthenia gravis, in which
NMJs of DeSyn muscles showed significantly decreased
post-synaptic area compared to NMJs of FaSyn muscles
[70]. The ability of TA (FaSyn) to focally cluster AChRs
at a higher rate could have an impact on its ability to
respond to disease pathology when the developmental
program is re-initiated, resulting in less NMJ pathology
than its fast-twitch counterpart, gastrocnemius (DeSyn).
Of note, TA was the only muscle evaluated that showed
upregulated AChR gamma (Additional File 1: Fig. S9),
which is known to be required for AChR clustering during development [37]. We hypothesize that the upregulated expression of AChR gamma in diseased TA is
related to its classification as a FaSyn muscle. Validation
of this idea that intersecting developmental and degenerative mechanisms contribute to NMJ pathology in SBMA
requires further validation.
NMJs in all three muscles evaluated in this study
showed significant changes in NFH levels and/or distribution. NFH is one of four proteins that make up neurofilament, a cytoskeletal protein necessary for structural
integrity and axon diameter [40]. While it is known that
phospho-NFH and NFL are not elevated in the plasma of
SBMA patients [38, 39], this finding does not preclude
their potential pathological importance. Genetic ablation

Discussion
Spinal and bulbar muscular atrophy (SBMA) is a debilitating neuromuscular neurodegenerative disease for
which there is no cure [13]. Symptoms reflect neuromuscular system degeneration and implicate dysfunctional communication at the primary functional synapse
of the motor unit, the neuromuscular junction (NMJ).
It has been shown previously in both SBMA and ALS
that fast-twitch motor units are more susceptible to
degeneration than slow-twitch motor units [19, 42, 73].
However, it is unknown whether pathology at the NMJ
differs between motor unit subtypes in SBMA. Based on
previous data showing a loss of fast-twitch muscle fibers in SBMA patients and SBMA mouse models [7, 23,
58, 73], we hypothesized that TA would show significant
NMJ pathology due to its classification as a fast-twitch
muscle, and that fast-twitch gastrocnemius would show
equal or less pathology than TA due to the higher percentage of type I (slow) and IIa (fast-oxidative) fibers
[3]. Correspondingly, we hypothesized that slow-twitch
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of Nefh and the subsequent alteration of the 4:1:1 neurofilament subunit ratio (NFL:NFM:NFH) has been shown
to alter the structural integrity of neurofilaments, resulting in decreased axon caliber and decreased neuronal
conduction velocity [12, 28, 76]. It is known that the
decreased uNFH observed in spinal motor neurons of the
SBMA transgenic mouse model evaluated in this study is
partially rescued upon disease amelioration, concomitant
with a partial rescue of motor function, suggesting pathological importance [6, 50]. The decrease in uNFH seen in
NMJs of the gastrocnemius provides evidence for a deficit at both ends of the motor neuron – in the soma [5]
and at the NMJ. In contrast, NMJs of knock-in mouse TA
show significantly increased pNFH. However, it should
be noted that in both knock-in and transgenic mice, there
is a subset of NMJs with higher pNFH intensity at the
axon terminal. Previous studies have shown that proteasome dysregulation by genetic ablation of USP14 results
in swellings of pNFH at the axon terminal [4]. Therefore,
proteasome dysregulation, known to be present in SBMA
[50, 59] might play a contributing role in the observed
increased pNFH intensity at this subset of NMJs.
The NFH deficit seen in this study could result in
decreased motor neuron conduction velocity, and therefore contribute to motor phenotypes. We considered carrying out electrophysiological studies to evaluate if motor
neurons showing a decrease in NFH levels and/or distribution exhibited reduced conduction velocity, and to
examine whether this correlated with glycolytic-to-oxidative fiber type switching seen in TA and gastrocnemius.
However, stimulation and recording of the sciatic nerve
would not allow for precise measurement of motor neurons innervating the muscles that have undergone fibertype switching. To provide electrophysiological evidence
for motor neurons innervating “switched” myofibers,
motor neurons would need to be individually separated
and evaluated for firing rate in vivo, which was beyond
the scope of this study. Future studies using in vitro models of the neuromuscular junction could yield important information on motor neuron firing rate changes in
SBMA models. In addition to its role in regulating axon
diameter, NFH also has a role at the pre-synaptic terminal in determining the size of the readily releasable pool
of synaptic vesicles and positioning organelles for energy
needs [14, 76]. For example, NFH interacts with mitochondria, which are more abundant at the NMJ than at
central synapses due to the high energy demands of the
NMJ [68]. It is known that mitochondrial functions are
altered in SBMA [52, 56]. Further experimentation to
evaluate mitochondrial density at the NMJ due to neurofilament loss is warranted, as a decrease in mitochondrial
density could contribute to neurotransmission failure in
SBMA. Notably, loss of NFH could also be a downstream

effect of neuronal dysfunction in the face of the toxic
gain-of-function of the polyglutamine-expanded AR.
Considering these data and the known roles of NFH in
the neuron, the deficit in NFH localization at the presynaptic terminal could result in less readily available
synaptic vesicles, fewer mitochondria, and a general lack
of structural integrity, altering the functional ability of
the nerve terminal. Future studies to elucidate the extent
to which neurofilament proteins (NFL, NFM, NFH, and
peripherin) are altered in SBMA mouse models in spinal cord motor neurons and sciatic nerve are needed to
fully understand the role of neurofilaments in SBMA
pathogenesis.
While fragmentation has canonically been used to
describe disease pathology at the NMJ [10, 63], we
observed significant NMJ fragmentation only in the TA
muscle. The modest changes in fragmentation seen in
this study, concomitant with significant changes in other
measures of NMJ pathology, highlights the importance
of including quantitative measurements when evaluating
a disease such as SBMA, where neuronal and muscular
alterations have a dynamic effect on the NMJ. While fragmentation was only significantly altered in TA, all three
muscles presented with significant decreases in post-synaptic area and endplate area. These post-synaptic changes
in soleus, TA, and gastrocnemius were accompanied by
decreased muscle fiber cross-sectional area in all three
muscles. It is known that post-synaptic size positively
correlates with muscle fiber cross-sectional area [29, 61].
Therefore, the decrease in post-synaptic size could be
secondary to the decrease in myofiber cross-sectional
area or due to primary NMJ pathology. The directionality of this pathology is unable to be discerned from these
studies. In addition, it is unclear whether the decrease
in cross-sectional area is due to muscle atrophy or fiber
type switching, as slow-twitch oxidative myofibers are
smaller than fast-twitch glycolytic myofibers [3]. All
three muscles evaluated showed a shift towards oxidative
metabolism as measured by NADH-diaphorase staining, except for transgenic soleus muscle, which showed
decreased NADH-diaphorase staining. The oxidative-toglycolytic shift in transgenic soleus could be a result of
altered metabolism, as mice deficient in mitochondrial
long-chain fatty acid synthesis show an oxidative-toglycolytic shift in slow-twitch soleus muscles [49]. The
decreased NADH staining could also be due to reduced
oxidative capacity, as mitochondrial depolarization and
ATP production is decreased in models of SBMA [7,
52, 58]. It is worth noting that we cannot derive information on the efficiency of energy production in these
muscles, as NADH-diaphorase staining measures only
the presence of the necessary mitochondrial enzyme
to deposit the stain, not mitochondrial activity, per se.
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Future metabolomic and proteomic studies on the muscles of these models will help to further deconstruct the
observed metabolic changes.
It is important to clarify that while muscle fibers show
convincing evidence of a glycolytic-to-oxidative shift in
metabolic state based on NADH-diaphorase staining,
these data do not support changes in myosin heavy chain
isotype expression in gastrocnemius or TA that would
indicate ‘fiber-type switching’ at a cytoskeletal protein
expression level. The distinction between metabolic and
cytoskeletal ‘fiber-type’ should be taken into consideration when evaluating neuromuscular disease, as the contractile properties of the myofiber may be discordant
with its metabolic state. Previous studies have shown
that mice defective in mitochondrial long chain fatty-acid
synthesis showed alterations in mitochondrial metabolism that were discordant with myosin heavy chain
expression [49]. Coordination of slow-twitch metabolic
and cytoskeletal characteristics requires co-activation of
PGC1α with Mef2 [35]. Mef2 transcriptional targets were
shown to be decreased in knock-in mouse muscles due
to sequestration of Mef2 in polyglutamine-expanded ARcontaining intranuclear inclusions [47]. The evaluation of
PGC1α protein levels in our study was inconclusive (data
not shown). Nonetheless, it is likely that Mef2-specific
transcriptional dysregulation [47], along with known
global transcriptional and translational deficits [33, 62],
contribute to the muscular cytoskeletal dysregulation
observed in this study. Interestingly, increased vinculin protein expression observed in both mouse models
of SBMA provides evidence for selective cytoskeletal
changes that correlate with metabolic glycolytic-to-oxidative fiber type switching, as vinculin is known to be
more highly expressed in slow-twitch oxidative myofibers [8]. Additionally, increased vinculin could be a sign
of neurotransmission failure, as vinculin levels are
known to increase upon denervation [57]. Understanding the nature of the distinct alteration in this myofiber
cytoskeletal component is the focus of future studies. Of
note, vinculin plays an analogous role in cardiac muscle.
Vinculin’s role in SBMA cardiac phenotypes should be
considered for further research, as SBMA patients have
an increased prevalence of Brugada Syndrome, a cardiac
syndrome that can lead to ventricular fibrillation and
early death [1, 32].
In this study, we observed some differences between
the two mouse models of SBMA. To understand the
model-specific pathology, we considered that the mouse
models used here differ in both age and polyglutamineexpanded AR expression. The transgenic model, which
over-expresses polyglutamine-expanded AR primarily in the nervous system, showed no significant NMJ
pathology at 6 months of age, despite significant motor

deficits [5, 77]. In contrast, the knock-in model, which
expresses endogenous polyglutamine-expanded AR,
showed significant NMJ pathology in gastrocnemius
muscle at 6 months of age. By 1-year of age, transgenic
mice showed significant pathology in all three muscles
evaluated. One possible explanation for the increased
NMJ pathology in the transgenic mice is the higher levels
of polyglutamine expanded AR in the spinal cord of the
transgenic model [5, 77]. The overexpression of mutant
AR in the spinal cord and brainstem could have contributed to broader NMJ pathology, independent of motor
unit subtype, since mutant AR is overexpressed in all
spinal cord neurons. The hypothesis that the differences
between models are due to differences in polyglutamine
expanded AR expression is not mutually exclusive of the
hypothesis that the differences between models are due
to the difference in age. The comparison of SBMA models of different ages is a limitation of this study; however
this comparison evaluated NMJ pathology at timepoints
known to be devoid of motor neuron loss. It is worth
noting that primary spinal cord cultures from both the
transgenic and knock-in mouse models exhibit substantial motor neuron cell death in response to hormone
treatment [20, 45, 48, 50], indicating intrinsic motor neuron vulnerability in both models. Notably, it is unknown
how polyglutamine-AR expression in glial cells of the
spinal cord or terminal Schwann cells of the NMJ might
affect the specificity of motor unit pathology. Further
research into the role of glia in SBMA pathogenesis is
needed, especially considering the importance of terminal Schwann cells in NMJ health.
A limitation of this study is the heterogenous nature
of the muscles evaluated. While both gastrocnemius and
TA represent “fast-twitch muscles”, they both contain a
mixture of muscle fiber types that are known to change
with age and anatomical location within the muscle [3,
25]. Because whole muscles were dissected and teased
into small bundles prior to staining and imaging of en
face NMJs, a random sample of NMJs was evaluated from
each muscle. This random sample, combined with the
heterogenous nature of the muscles evaluated, may have
limited the power of this study to detect NMJ pathology
in specific motor unit subtypes. However, while these
data cannot provide insight on individual motor units,
they do provide evidence to support increased vulnerability of muscles containing primarily fast-twitch myofibers in SBMA mouse models.
Our model (Fig. 10) proposes that glycolytic-to-oxidative
metabolic fiber-type alterations and decreased myofiber
cross-sectional area are correlated with a decrease in NMJ
post-synaptic membrane size and other NMJ pathologies, making fast-twitch motor units more vulnerable
to SBMA pathogenesis than slow-twitch motor units.
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Fig. 10 Model for NMJ and muscle pathology in SBMA mouse models. NMJ pathology reflects the contractile properties of the motor unit and
metabolic machinery of the muscle fiber. We hypothesize that differences in the developmental subtype of the muscle also contributes to the
response to disease. Slow-twitch soleus NMJs showed significant pre- and post-synaptic changes, with modest muscular pathology. Fast-twitch
TA and gastrocnemius showed differing levels of NMJ pathology despite severe muscle atrophy and metabolic changes in both muscles. TA NMJs
showed primarily post-synaptic pathology, while gastrocnemius showed significant pre- and post-synaptic NMJ pathology. We hypothesize the
lower level of NMJ pathology in TA is due to the fast-synapsing (FaSyn) properties of TA during development, compared to the delayed-synapsing
(DeSyn) properties of gastrocnemius. Together, the contractile properties of the motor unit and the developmental properties of the muscle fiber
contribute to NMJ pathology in SBMA mouse models

Glycolytic-to-oxidative motor unit changes and myofiber
atrophy could be the result of either denervation, neuromuscular transmission dysfunction due to NMJ structural defects, or changes in motor neuron firing rate.
Equally likely is that changes in myofiber metabolism and
a decrease in fiber size promote changes in motor neuron firing rate and NMJ reorganization. Our quantitative
analyses of NMJ pathology were largely in keeping with
our hypothesis that NMJ pathology is correlated with
muscle type vulnerability seen in SBMA mouse models
and SBMA patients. Moreover, our study revealed a novel
relationship between neurofilament dysregulation at the
NMJ and both pre- and post-synaptic pathology. However,
our observations of differences in NMJ pathology between
gastrocnemius and TA suggest that motor unit vulnerability may also be impacted by inherent differences in the
rate of synapse formation (e.g., fast synapsing vs. delayed
synapsing). In addition, the oxidative shift in gastrocnemius and TA muscles, in the absence of myosin heavy
chain isoform switching, may also contribute to the NMJ
pathologies observed here. A deep understanding of the

relationship between NMJ pathology and both neuronal
and muscle alterations is likely to provide novel insights
into approaches to enhance NMJ neurotransmission and
disease progression in SBMA.
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